Skip to main content

UBX

Stock
Health Care
Biotechnology

Performance overview

UBX Price
Price Chart

Forward-looking statistics

Beta
1.68
Risk
100.00%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

unity biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. unity's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. more information is available at www.unitybiotechnology.com.

Company info

SectorHealth Care
IndustryBiotechnology
Employees32
Market cap$26.9M

Fundamentals

Enterprise value$12.3M
Revenue$0.0
Revenue per employee—
Profit margin0.00%
Debt to equity-110.28

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$1.63
Dividend per share—
Revenue per share$0.00
Avg trading volume (30 day)$177K
Avg trading volume (10 day)$356K
Put-call ratio—

Macro factor sensitivity

Growth+6.3
Credit-2.0
Liquidity-0.4
Inflation+1.9
Commodities+1.7
Interest Rates-1.8

Valuation

Dividend yield0.00%
PEG Ratio-0.17
Price to sales—
P/E Ratio-0.17
Enterprise Value to Revenue—
Price to book-24.83

Upcoming events

Next earnings dayApril 23, 2025
Next dividend day—
Ex. dividend day—

News

UBX Stock Down 29% on Mixed Results From Phase II Eye Disease Study

UNITY Biotechnology stock loses 29% as the mid-stage DME study of the lead candidate, UBX1325, fails to achieve statistical significance for the primary goal.

Zacks Investment Research (March 25, 2025)
Unity Biotechnology Unveils Mixed Data From Study For Diabetes-Related Blindness, Stock Falls

Unity Biotechnology, Inc. UBX stock plummeted on Monday after the company released results from its latest study.

Benzinga (March 24, 2025)
This biotech company is trying to stop or reverse age-related diseases

Keith Leonard, chairman and CEO of Unity Biotechnology, said that his company's mission is to extend the human "healthspan," the period in someone's life that is unburdened by disease or pain.

CNBC Television (September 13, 2018)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free